<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57140">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02066233</url>
  </required_header>
  <id_info>
    <org_study_id>13-008214</org_study_id>
    <nct_id>NCT02066233</nct_id>
  </id_info>
  <brief_title>Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy</brief_title>
  <official_title>Prospective Study to Compare the Efficacy of E.G.Scan to Detect Barrett's Esophagus Compared With Standard Endoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>IntroMedic Co, LTD</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <authority>United States: Institutional Review Board</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Will EG Scan (transnasal endoscopy) determine presence of Barrett's Esophagus, esophagitis
      and hiatal hernia as well as standard sedated endoscopy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      To evaluate the sensitivity and specificity of E.G.Scan (transnasal endoscopy) in diagnosing
      Barrett's Esophagus (using standardized endoscopic criteria) compared with the gold standard
      white light sedated endoscopy.

      To look at the sensitivity and specificity of E.G.Scan (transnsasal endoscopy) in diagnosing
      short segment Barrett's Esophagus, esophagitis and hiatus hernia.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2014</start_date>
  <completion_date type="Anticipated">March 2016</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Number of subjects with comparible results using EG scan (transnsal endoscopy) versus clinical sedated endoscopy</measure>
    <time_frame>Within 48 hours</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of subjects with a 5+ experience using 10-point VAS</measure>
    <time_frame>Two weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measured with a 10-point VAS where 0 represents the worse and 10 represents the best experience.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Barrett's Esophagus</condition>
  <arm_group>
    <arm_group_label>Barrett's Esophagus</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EG scan (transnasal endoscopy)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Reflux and/or heartburn</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>EG scan (transnasal endoscopy)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>EG scan (transnasal endoscopy)</intervention_name>
    <arm_group_label>Barrett's Esophagus</arm_group_label>
    <arm_group_label>Reflux and/or heartburn</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Adult participants aged 18 years or above who are referred for routine upper GI
             endoscopy for Barrett's Esophagus surveillance, varices surveillance and dyspepsia.

          2. Able and willing to give informed consent.

        Exclusion Criteria:

          1. Patients known to be intolerant to endoscopy.

          2. Patients with history of broken nose, deviated nasal septum or disease of the nasal
             cavity.

          3. Patients not clinically fit for endoscopy as judged by their care team.

          4. Pregnant women.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Prasad G Iyer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Prasad G Iyer, MD</last_name>
    <phone>507-255-6930</phone>
    <email>iyer.prasad@mayo.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Michele L Johnson</last_name>
    <phone>507-293-5307</phone>
    <email>johnson.michele@mayo.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo Clinic</name>
      <address>
        <city>Rochester</city>
        <state>Minnesota</state>
        <zip>55905</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michele L Johnson</last_name>
      <phone>507-293-5307</phone>
      <email>johnson.michele@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Prasad G Iyer, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <lastchanged_date>March 25, 2014</lastchanged_date>
  <firstreceived_date>February 3, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Prasad G. Iyer</investigator_full_name>
    <investigator_title>Associate Professor of Medicine</investigator_title>
  </responsible_party>
  <keyword>Barrett's</keyword>
  <keyword>esophagus</keyword>
  <keyword>reflux</keyword>
  <keyword>heartburn</keyword>
  <keyword>screening</keyword>
  <is_fda_regulated>Yes</is_fda_regulated>
  <is_section_801>Yes</is_section_801>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Barrett Esophagus</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
